Santangelo Gloria, Ielasi Alfonso, Pellicano Mariano, Latib Azeem, Tespili Maurizio, Donatelli Francesco
San Paolo Hospital, Division of Cardiology, Department of Health Sciences, University of Milan, Via Antonio di Rudinì 8, 20142 Milan, Italy.
Clinical and Interventional Cardiology Unit, Istituto Clinico Sant'Ambrogio, Via Faravelli 16, 20149 Milan, Italy.
J Clin Med. 2022 Jan 19;11(3):499. doi: 10.3390/jcm11030499.
Over the last 15 years, the management of aortic valve disease has been changed by transcatheter aortic valve replacement, which has become the standard of care across the entire spectrum of surgical risk. As a result of continuous evolution of this technique, several next-generation transcatheter heart valves (THVs) have been developed to minimize procedural complications and improve patient outcomes. This review aims to provide an update on the new generation THVs and delivery systems.
在过去15年里,经导管主动脉瓣置换术改变了主动脉瓣疾病的治疗方式,该技术已成为所有手术风险范围内的治疗标准。由于这项技术的不断发展,已经研发出了几种新一代经导管心脏瓣膜(THV),以尽量减少手术并发症并改善患者预后。本综述旨在介绍新一代THV及其输送系统的最新情况。